486
H. G. Bonacorso, A. Ferla, C. A. Cechinel, N. Zanatta, and M. A. P. Martins
Vol 45
(s, 1H, H-5), 2.28 (s, 3H, CH3). 13C NMR (DMSO-d6): δ = 169.0
(C=O), 164.8 (C-6), 158.1 (C-2), 156.4 (q, JCF = 35, C-4),
149.2, 140.5, 128.8, 123.7, (6C, ArC), 120.3 (q, 1JCF = 275, CF3),
108.0 (C-5), 24.7 (CH3). MS [m/z (%)] for C13H9F3N4O3
(326.06): 326 (M+,24), 284 (100), 238 (19). Anal. Calcd. for
C13H9F3N4O3 (326.06): C, 47.86; H, 2.78; N, 17.17%. Found: C,
47.76; H, 2.46; N, 17.02%.
CF3), 105.7 (C-5), 24.9 (CH3). MS [m/z (%)] for C11H8SF3N3O
(287.03): 287 (M+,67), 245 (100), 69 (5). Anal. Calcd. for
C11H8SF3N3O (287.03): C, 45.99; H, 2.81; N, 14.63%. Found: C,
45.90; H, 2.53; N, 14.60%.
2
4-Trifluoromethyl-6-(2-furyl)-2-acetylaminopyrimidine (3n).
This compound was obtained as white solid; yield 52%; mp. 126
1
– 128 °C. H NMR (DMSO-d6): δ = 8.07 (s, 1H, ArH), 7.79 (s,
1H, H-5), 7.60 (d, 1H, ArH, J = 2.5), 6.82 (t, 1H, ArH, J =1.8),
2.28 (s, 3H, CH3). 13C NMR (DMSO-d6): δ = 170.0 (C=O),
158.5 (C-6), 158.3 (C-6), 155.5 (q, 2JCF = 35, C-4), 150.2, 147.7,
115.7, 113.5 (4C, Furyl), 120.5 (q, 1JCF = 275, CF3), 105.3 (C-5),
25.0 (CH3). MS [m/z (%)] for C11H8F3N3O2 (271.08): 271
(M+,71), 229 (100). Anal. Calcd. for C11H8F3N3O2 (271.08): C,
48.72; H, 2.97; N, 15.49%. Found: C, 48.96; H, 3.01; N,
15.66%.
General Procedure for the Preparation of Fused-
cycloalkane 4-Trifluoromethyl-2-acetylaminopyrimidines
(3o-p). To a stirred solution of 1-acetylguanidine (0.707g, 7
mmol) in propan-2-ol (10 mL) kept at room temperature (20 -
25ºC), was added pure ketone 1 (5 mmol) and boron trifluoride
diethyl etherate (sol. 45% in MeOH) (10 drops). The mixture
was stirred for 20 h at 80 - 85 ºC. After cooling (< 10°C), the
crystalline solids were filtered off, washed with propan-2-ol to
remove the residual 1-acetylguanidine and recrystallized from
ethyl acetate.
4-Trifluoromethyl-5,6,7,8-tetrahydro-2-acetylaminoquin-
azoline (3o). This compound was obtained as white solid; yield
42%; mp. 152 – 154 °C. 1H NMR (DMSO-d6): δ = 10.74 (s, 1H,
NH), 2.82 (m, 4H, 2CH2), 2.18 (s, 3H, CH3), 1.81 (s, 4H, 2CH2).
13C NMR (DMSO-d6): δ = 171.3 (C=O), 169.2 (C-8a), 154.8 (C-
2), 151.8 (q, 2JCF = 33, C-4), 121.4 (q, 1JCF = 277, CF3), 127.6 (C-
4a), 31.0 (CH2), 26.5 (CH2), 26.3 (CH2), 25.4 (CH2), 25.1 (CH2),
24.9 (CH3). MS [m/z (%)] for C11H12F3N3O (259.23): 259
(M+,24), 216 (100), 189 (43). Anal. Calcd. for C11H12F3N3O
(259.23): C, 50.97; H, 4.67; N, 16.21%. Found: C, 51.07; H,
4.71; N, 16.30%.
4-Trifluoromethyl-6,7,8,9-tetrahydro-5H-cyclohepta[d]-2-
acetylaminopyrimidine (3p). This compound was obtained as
white solid; yield 62%; mp. 167 – 169 °C. 1H NMR (DMSO-d6):
δ = 10.75 (s, 1H, NH), 3.05 (m, 2H, CH2), 2.84 (m, 2H, CH2),
2.19 (s, 3H, CH3), 1.82 (m, 2H, CH2), 1.64 (m, 2H, CH2), 1.61
(m, 2H, CH2). 13C NMR (DMSO-d6): δ = 177.0 (C=O), 169.2
(C-9a), 154.8 (C-2), 150.2 (q, 2JCF=35, C-4), 121.5 (q, 1JCF =275,
CF3,), 127.6 (C-4a), 31.0 (CH2), 26.5 (CH2), 26.3 (CH2), 25.4
(CH2), 25.1 (CH2), 24.9 (CH3). MS [m/z (%)] for C12H14F3N3O
(273.25): 273 (M+, 29), 231 (100), 203 (29). Anal. Calcd. for
C12H14F3N3O (273.25): C, 52.75; H, 5.16; N, 15.38%. Found: C,
52.69; H, 5.12; N, 15.62%.
4-Trifluoromethyl-5-methyl-6-(4-chlorophenyl)-2-acetyl-
aminopyrimidine (3i). This compound was obtained as white
solid; yield 39%; mp. 158 – 160 °C. 1H NMR (DMSO-d6): δ =
10.95 (s, 1H, NH), 7.70 (d, 2H, ArH, J = 8.8), 7.62 (d, 2H, ArH,
J = 8.8), 2.33 (s, 3H, CH3), 2.21 (s, 3H, CH3). 13C NMR
(DMSO-d6): δ = 169.2 (C=O), 169.0 (C-6), 155.0 (C-2), 153.4
2
(q, JCF = 33.1, C-4), 135.6, 134.8, 131.1, 128.4, (6C, ArC),
1
123.1 (q, JCF = 277, CF3), 118.3 (C-5), 24.6 (CH3), 13.8 (CH3).
MS [m/z (%)] for C14H11F3N3O2 (329.11): 329 (M+,24), 286
(100). Anal. Calcd. for C14H11F3N3O2 (329.11): C, 51.00; H,
3.36; N, 12.74%. Found: C, 50.88; H, 2.99; N, 12.69%.
4-Trifluoromethyl-5-methyl-6-(4-methoxyphenyl)-2-acetyl-
aminopyrimidine (3j). This compound was obtained as white
1
solid; yield 36%; Mp. 145 – 147 °C. H NMR (DMSO-d6): δ =
10.84 (s, 1H, NH), 7.66 (d, 2H, ArH, J = 8.8), 7.09 (d, 2H, ArH,
J = 8.8), 3.85 (s, 3H, OCH3), 2.36 (s, 3H, CH3), 2.23 (s, 3H,
CH3). 13C NMR (DMSO-d6): δ = 169.5 (C=O), 169.2 (C-6),
160.0 (ArC), 155.0 (C-2), 153.2 (q, 2JCF = 34, C-4), 131.0, 128.9,
1
113.6, 113.1 (5C, ArC), 121.4 (q, JCF = 277, CF3), 119.8 (C-5),
55.2 (OCH3), 24.5 (CH3), 13.9 (CH3). MS [m/z (%)] for
C15H14F3N3O2 (325.29): 325 (M+,71), 283 (100). Anal. Calcd.
for C15H14F3N3O2 (325.29): C, 55.39; H, 4.34; N, 12.92%.
Found: C, 55.23; H, 4.33; N, 12.90%.
4-Trifluoromethyl-6-biphenyl-2-acetylaminopyrimidine (3k).
This compound was obtained as white solid; yield 70%; mp. 186
1
– 188 °C. H NMR (DMSO-d6): δ = 11.06 (s, 1H, NH), 8.43-
8.47 (d, 2H, ArH, J = 8.5), 8.25 (s, 1H, H-5), 7.88-7.92 (d, 2H,
ArH, J = 8.5), 7.78-7.83 (m, 2H, ArH), 7.74-7.57 (m, 3H, ArH),
2.30 (s, 3H, CH3). 13C NMR (DMSO-d6): δ = 169.2 (C=O),
166.7 (C-6), 158.1 (C-2). 155.0 (q, 2JCF = 35, C-4), 143.6, 138.8,
133.8, 128.9, 128.2, 128.1, 127.0, 126.7 (12C, ArC), 120.7 (q,
1JCF = 275, CF3), 107.0 (C-5), 24.8 (CH3). MS [m/z (%)] for
C19H14F3N3O (357.11): 357 (M+,62), 315 (100). Anal. Calcd. for
C19H14F3N3O (357.11): C, 63.86; H, 3.95; N, 11.76%. Found: C,
63.53; H, 3.97; N, 11.70%.
4-Trifluoromethyl-6-naphthyl-2-acetylaminopyrimidine (3l).
This compound was obtained as white solid; yield 35%; mp. 127
1
– 128 °C. H NMR (DMSO-d6): δ = 11.13 (s, 1H, NH), 8.50-
8.52 (m, 1H, ArH), 8.12 - 8.14 (d, 1H, ArH, J = 8.3), 8.03 - 8.05
(m, 1H, ArH), 7.89 (s, 1H, H-5), 7.86-7.88 (d, 2H, ArH, J = 8.0),
7.65-7.67 (d, 1H, ArH, J = 7.6), 7.59-7.67 (m, 2H, ArH), 2.31 (s,
3H, CH3). 13C NMR (DMSO-d6): δ = 170.1 (C=O), 169.2 (C-6),
General Procedures for the Preparation of 6-Substituted 4-
Trifluoromethyl-2-aminopyrimidines (4a, 4b, 4e, 4g).
2
157.8 (C-2), 155.4 (q, JCF = 35, C-4), 134.0, 133.4, 131.0,
129.8, 128.9, 128.4, 127.2, 126.9, 125.8, 125.2 (10C, ArC),
1
120.3 (q, JCF = 275, CF3), 111.9 (C-5), 24.7 (CH3). MS [m/z
Method A [4]. To a stirred solution of acetylaminopyrim-
idines 3 (2 mmol) in methanol (20 mL) kept at room temperature
(20 - 25ºC), was added in one portion Fe(NO3)3•9H2O (0.2
mmol, 0.08g). The mixture was stirred for 24 h at 40 ºC. After
cooling (< 5°C), the crystalline solids were collected by
filtration and recrystallized from ethanol (58 – 90 % yields).
(%)] for C17H12F3N3O (331.29): 331 (M+, 62), 288 (100), 220
(52). Anal. Calcd. for C17H12F3N3O (331.29): C, 61.63; H, 3.65;
N, 12.68%. Found: C, 61.87; H, 3.68; N, 12.87%.
4-Trifluoromethyl-6-(2-thienyl)-2-acetylaminopyrimidine
(3m). This compound was obtained as white solid; yield 48%;
mp. 143 – 145 °C. 1H NMR (DMSO-d6): δ = 8.34 (d, 1H, ArH, J
=3.9), 8.13 (s, 1H, H-5), 7.95 (d, 1H, ArH, J = 4.9), 7.30 (t, 1H,
ArH, J = 4.4), 2.29 (s, 3H, CH3). 13C NMR (DMSO-d6): δ =
169.5 (C=O), 162.2 (C-6), 158.1 (C-2), 155.5 (q, 2JCF = 35, C-4),
Method
B [20]. To a stirred solution of acetylamino-
pyrimidines 3 (2 mmol) in ethanol (15 mL) kept at room
temperature (20 - 25ºC), was added, in one portion, concentrated
HCl (15 mL). The mixture was refluxed for 20 h. After cooling (<
5°C), the reaction was neutralized with an aqueous solution of
1
128.9, 130.9, 132.9, 140.7, (4C, Thienyl), 120.5 (q, JCF = 275,